Lv1
54 积分 2025-10-11 加入
Phosphoramidate peptidomimetics: A new class of PSMA inhibitors as PET agents for prostate cancer
29天前
已关闭
1296 RATIONALLY DESIGNED PEPTIDOMIMETICS TARGET ANDROGEN RECEPTOR SIGNALING IN PROSTATE CANCER
29天前
已完结
Androgen Receptor Antagonism By Divalent Ethisterone Conjugates In Castrate-Resistant Prostate Cancer Cells
29天前
已完结
Abstract 3441: A multivalent peptoid conjugate that inhibits therapy-resistant prostate cancer cell proliferation by modulating androgen receptor transcriptional activity
29天前
已关闭
Recent advances in anticancer peptoids
29天前
已完结
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer
30天前
已完结
P0120 De novo design delivers ACP3-specific macrocycle peptide for ⁶⁸GA-based PET imaging of metastatic castration-resistant prostate cancer
1个月前
已完结
Development of peptidomimetic inhibitors of the ERG gene fusion product in prostate cancer
1个月前
已完结
Enzalutamide and Leuprolide Acetate in Non-Metastatic Hormone-Sensitive Prostate Cancer: The Sooner the Better?
1个月前
已完结
Enzalutamide and leuprolide acetate in non-metastatic hormone-sensitive prostate cancer: the sooner the better?
1个月前
已关闭
皖公网安备34019202002308
